Untitled document
National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012)
made under sections 93 and 93AB of the
National Health Act 1953
Compilation No. 20
Compilation date: 1 September 2019
Includes amendments up to: PB 69 of 2019
Registered: 12 September 2019
About this compilation
This compilation
This is a compilation of the National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012) that shows the text of the law as amended and in force on 1 September 2019 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register ( The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
1............ Name of Determination................................................................................................. 1
4............ Definitions..................................................................................................................... 1
5............ Pharmaceutical benefits................................................................................................. 1
6............ Maximum quantity........................................................................................................ 2
Schedule—Pharmaceutical benefits that may be supplied by prescriber bag suppliers 3
Endnotes6
Endnote 1—About the endnotes 6
Endnote 2—Abbreviation key 7
Endnote 3—Legislation history 8
Endnote 4—Amendment history 10
1 Name of Determination
(1) This Determination is the National Health (Prescriber bag supplies) Determination 2012.
(2) This Determination may also be cited as PB 73 of 2012.
4 Definitions
In this Instrument:
Act means the National Health Act 1953.
authorised midwife has the same meaning as in subsection 84(1) of the Act.
authorised nurse practitioner has the same meaning as in subsection 84(1) of the Act.
prescriber bag supplier in relation to a pharmaceutical benefit means a medical practitioner, authorised midwife or authorised nurse practitioner authorised to supply the pharmaceutical benefit under this Determination.
maximum quantity means maximum quantity or number of units.
pharmaceutical benefit has the same meaning as in subsection 84(1) of the Act.
pharmaceutical benefit has a drug has the same meaning as in subsection 84(1) of the Act.
prescriber bag provisions has the same meaning as in subsection 84(1) of the Act.
5 Pharmaceutical benefits
(1) For subsection 93(1) of the Act, a medical practitioner is authorised to supply a pharmaceutical benefit having a drug in a form mentioned in the Schedule if the initials MP are mentioned for the drug and the form in the column headed ‘Prescriber Bag Supplier’ in the Schedule.
(2) For subsection 93AB(1) of the Act, an authorised nurse practitioner is authorised to supply a pharmaceutical benefit having a drug in a form mentioned in the Schedule if the initials NP are mentioned for the drug and the form in the column headed ‘Prescriber Bag Supplier’ in the Schedule.
Note: A pharmaceutical benefit is a brand of a drug in a form with a manner of administration. The drugs are declared, and the forms, manners of administration and brands are determined, by legislative instrument under subsections 85(2), (3), (5) and (6) of the Act, respectively.
6 Maximum quantity
(1) The maximum quantity of pharmaceutical benefits having a drug in a form mentioned in the Schedule which may be obtained by a prescriber bag supplier in any calendar month is the quantity mentioned for the drug and the form in the Schedule under the column headed ‘Maximum Quantity’.
(2) The maximum quantity may be obtained for one pharmaceutical benefit only having a drug in a form mentioned in a Group during a calendar month.
(3) A quantity, up to the maximum quantity, for a pharmaceutical benefit may be obtained at a particular time only if, at that time, the total quantity of every pharmaceutical benefit having a particular drug in a particular form in the Group, previously obtained in accordance with the prescriber bag provisions of the Act and still in the possession of the supplier, is less than the maximum quantity for a pharmaceutical benefit having that drug in that form.
(4) For this section, a Group is each drug in a form mentioned in the Schedule which has the same number mentioned in the column headed ‘Group Number’.
Schedule—Pharmaceutical benefits that may be supplied by prescriber bag suppliers
| Group Number | Listed Drug | Form | Prescriber Bag Supplier | Maximum Quantity |
| 1 | Adrenaline (epinephrine) | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | MP, NP | 5 |
| 2 | Atropine | Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL | MP, NP | 10 |
| 3 | Benzatropine | Injection containing benzatropine mesilate 2 mg in 2 mL | MP, NP | 5 |
| 4 | Benzylpenicillin | Powder for injection 600 mg (as sodium) | MP, NP | 5 |
| 4 | Procaine benzylpenicillin | Injection 1.5 g in disposable syringe | MP, NP | 5 |
| 5 | Benzylpenicillin | Powder for injection 3 g (as sodium) | MP, NP | 1 |
| 6 | Chlorpromazine | Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | MP, NP | 10 |
| 6 | Haloperidol | Injection 5 mg in 1 mL | MP, NP | 10 |
| 7 | Clonazepam | Oral liquid 2.5 mg per mL, 10 mL | MP, NP | 1 |
| 8 | Dexamethasone | Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL | MP, NP | 5 |
| 8 | Hydrocortisone | Injection 100 mg (as sodium succinate) with 2 mL solvent | MP, NP | 2 |
| 8 | Hydrocortisone | Injection 250 mg (as sodium succinate) with 2 mL solvent | MP, NP | 1 |
| 9 | Diazepam | Injection 10 mg in 2 mL | MP, NP | 5 |
| 10 | Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre‑filled syringe | MP, NP | 10 |
| 11 | Furosemide | Injection 20 mg in 2 mL | MP, NP | 5 |
| 12 | Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | MP, NP | 1 |
| 13 | Glyceryl Trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | MP, NP | 1 |
| 14 | Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | MP, NP | 5 |
| 15 | Lidocaine | Injection containing lidocaine hydrochloride 50 mg in 5 mL | MP, NP | 5 |
| 16 | Methoxyflurane | Liquid for inhalation 999.9 mg per g, 3 mL (with inhaler) | MP | 1 |
| 17 | Metoclopramide | Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL | MP, NP | 10 |
| 17 | Prochlorperazine | Injection containing prochlorperazine mesilate 12.5 mg in 1 mL | MP, NP | 10 |
| 18 | Morphine | Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL | MP, NP | 5 |
| 18 | Morphine | Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL | MP, NP | 5 |
| 18 | Morphine | Injection containing morphine sulfate pentahydrate 15 mg in 1 mL | MP, NP | 5 |
| 18 | Morphine | Injection containing morphine sulfate pentahydrate 30 mg in 1 mL | MP, NP | 5 |
| 19 | Naloxone | Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule | MP, NP | 10 |
| 21 | Promethazine | Injection containing promethazine hydrochloride 50 mg in 2 mL | MP, NP | 10 |
| 22 | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation) | MP, NP | 1 |
| 22 | Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | MP, NP | 1 |
| 22 | Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 | MP, NP | 1 |
| 23 | Salbutamol | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | MP, NP | 1 |
| 23 | Salbutamol | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 | MP, NP | 1 |
| 25 | Tramadol | Injection containing tramadol hydrochloride 100 mg in 2 mL | MP, NP | 5 |
| 26 | Midazolam | Injection 5 mg (as hydrochloride) in 1 mL | MP, NP | 10 |
| 27 | Phytomenadione | Injection 10 mg in 1 mL | MP | 5 |
| 28 | Oxytocin | Injection 10 I.U. in 1 mL | MP | 5 |
| 29 | Benzathine benzylpenicillin | Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre‑filled syringe | MP, NP | 10 |
Endnotes
Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Editorial changes
The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.
If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.
If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.
Endnote 2—Abbreviation key
| ad = added or inserted | o = order(s) |
| am = amended | Ord = Ordinance |
| amdt = amendment | orig = original |
| c = clause(s) | par = paragraph(s)/subparagraph(s) |
| C[x] = Compilation No. x | /sub‑subparagraph(s) |
| Ch = Chapter(s) | pres = present |
| def = definition(s) | prev = previous |
| Dict = Dictionary | (prev…) = previously |
| disallowed = disallowed by Parliament | Pt = Part(s) |
| Div = Division(s) | r = regulation(s)/rule(s) |
| ed = editorial change | reloc = relocated |
| exp = expires/expired or ceases/ceased to have | renum = renumbered |
| effect | rep = repealed |
| F = Federal Register of Legislation | rs = repealed and substituted |
| gaz = gazette | s = section(s)/subsection(s) |
| LA = Legislation Act 2003 | Sch = Schedule(s) |
| LIA = Legislative Instruments Act 2003 | Sdiv = Subdivision(s) |
| (md) = misdescribed amendment can be given | SLI = Select Legislative Instrument |
| effect | SR = Statutory Rules |
| (md not incorp) = misdescribed amendment | Sub‑Ch = Sub‑Chapter(s) |
| cannot be given effect | SubPt = Subpart(s) |
| mod = modified/modification | underlining = whole or part not |
| No. = Number(s) | commenced or to be commenced |
Endnote 3—Legislation history
| Name | Registration | Commencement | Application, saving and transitional provisions |
| PB 73 of 2012 | 27 Sept 2012 (F2012L01955) | 1 Oct 2012 (s 2) | |
| PB 100 of 2012 | 29 Nov 2012 (F2012L02289) | 1 Dec 2012 (s 2) | — |
| PB 23 of 2013 | 24 Apr 2013 (F2013L00681) | 1 May 2013 (s 2) | — |
| PB 90 of 2013 | 20 Dec 2013 (F2013L02168) | 1 Jan 2014 (s 2) | — |
| PB 91 of 2014 | 28 Nov 2014 (F2014L01607) | 1 Dec 2014 (s 2) | — |
| PB 107 of 2014 | 22 Dec 2014 (F2014L01789) | 1 Jan 2015 (s 2) | — |
| PB 7 of 2015 | 15 Jan 2015 (F2015L00042) | 1 Feb 2015 (s 2) | — |
| PB 14 of 2015 | 25 Feb 2015 (F2015L00209) | 1 Mar 2015 (s 2) | — |
| PB 29 of 2015 | 26 Mar 2015 (F2015F00339) | 1 Apr 2015 (s 2) | — |
| PB 42 of 2015 | 24 Apr 2015 (F2015L00588) | 1 May 2015 (s 2) | — |
| PB 115 of 2015 | 1 Dec 2015 (F2015L01903) | 1 Dec 2015 (s 2) | — |
| PB 43 of 2016 | 31 May 2016 (F2016L00880) | 1 June 2016 (s 2) | — |
| PB 64 of 2016 | 19 July 2016 (F2016L01195) | 1 Aug 2016 (s 2) | — |
| PB 17 of 2017 | 30 Mar 2017 (F2017L00356) | 1 Apr 2017 (s 2) | — |
| PB 37 of 2017 | 31 May 2017 (F2017L00621) | 1 June 2017 (s 2) | — |
| PB 5 of 2018 | 24 Jan 2018 (F2018L00056) | 1 Feb 2018 (s 2) | — |
| PB 14 of 2018 | 1 Mar 2018 (F2018L00173) | 1 Mar 2018 (s 2) | — |
| PB 53 of 2018 | 29 June 2018 (F2018L00955) | 1 July 2018 (s 2) | — |
| PB 66 of 2018 | 31 July 2018 (F2018L01072) | 1 Aug 2018 (s 2) | — |
| PB 101 of 2018 | 29 Nov 2018 (F2018L01630) | 1 Dec 2018 (s 2) | — |
| PB 69 of 2019 | 30 Aug 2019 (F2019L01124) | 1 Sept 2019 (s 2) | — |
Endnote 4—Amendment history
| Provision affected | How affected |
| s 2............................................. | rep LIA s 48D |
| s 3............................................. | rep LIA s 48C |
| Schedule | |
| Schedule................................... | am PB 100 of 2012; PB 23 and 90 of 2013; PB 91 and 107 of 2014; PB 7, 14, 29, 42 and 115 of 2015; PB 43 of 2016; PB 64 of 2016; PB 17 of 2017; PB 37 of 2017; PB 5 of 2018; PB 14 of 2018; PB 53 of 2018 |
| ed C17 | |
| am PB 66 of 2018; PB 101 of 2018; PB 69 of 2019 |
0
0
0